Inhaled mRNA Respiratory Vaccines to Be Developed Under $20.7 Million Government Contract
The Icahn School of Medicine at Mount Sinai Health System has received a five-year federal agreement worth approximately $20.7 million to develop mRNA vaccine technologies targeting respiratory pathogens. The funding comes from the U.S. Department of Defense through the Defense Threat Reduction Agency (DTRA), with support provided through its Joint Science and Technology Office (JSTO) […]